Unraveling the Structure and Mechanism of the MST(ery) Enzymes
Catherine L. Shelton, Audrey L. Lamb
Index: 10.1016/j.tibs.2018.02.011
Full Text: HTML
Abstract
The menaquinone, siderophore, and tryptophan (MST) enzymes transform chorismate to generate precursor molecules for the biosynthetic pathways defined in their name. Kinetic data, both steady-state and transient-state, and X-ray crystal structures indicate that these enzymes are highly conserved both in mechanism and in structure. Because these enzymes are found in pathogens but not in humans, there is considerable interest in these enzymes as drug design targets. While great progress has been made in defining enzyme structure and mechanism, inhibitor design has lagged behind. This review provides a detailed description of the evidence that begins to unravel the mystery of how the MST enzymes work, and how that information has been used in inhibitor design.
Latest Articles:
Hypothesis on the Synchronistic Evolution of Autotrophy and Heterotrophy
2018-04-11
[10.1016/j.tibs.2018.03.008]
A Lethal Channel between the ATP Synthase Monomers
2018-03-16
[10.1016/j.tibs.2018.02.013]
Affimer Proteins: Theranostics of the Future?
2018-03-14
[10.1016/j.tibs.2018.03.001]
Evolving Linear Chromosomes and Telomeres: A C-Strand-Centric View
2018-03-14
[10.1016/j.tibs.2018.02.008]
Homing in: Mechanisms of Substrate Targeting by Protein Kinases
2018-03-12
[10.1016/j.tibs.2018.02.009]